Clinical Trial Detail

NCT ID NCT03396471
Title Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoosier Cancer Research Network
Indications

carcinoma

squamous cell carcinoma

adenocarcinoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.